Human gene therapy - JoVE Visualize

Showing results (2041-2050 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|April 11, 2000

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell lineS Osanto, P P Schiphorst, N I Weijl, et al.

Human Gene Therapy|April 11, 2000

Retroviral preparations derived from PA317 packaging cells contain inhibitors that copurify with viral particles and are devoid of viral vector RNAJ Seppen, S Barry, G M Lam, et al.

Human Gene Therapy|April 25, 2000

Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA moleculeJ Lisziewicz, G Zeng, C Gratas, et al.

Human Gene Therapy|April 25, 2000

Photochemical transfection: a new technology for light-induced, site-directed gene deliveryA Høgset, L Prasmickaite, T E Tjelle, et al.

Human Gene Therapy|April 25, 2000

Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expressionJ M Vicat, S Boisseau, P Jourdes, et al.

Human Gene Therapy|August 17, 2000

Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's diseaseM Bauer, M Meyer, L Grimm, et al.

Human Gene Therapy|August 17, 2000

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapyY Chen, D C Yu, D Charlton, et al.

Human Gene Therapy|August 17, 2000

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutantJ Qiao, M E Black, M Caruso

Human Gene Therapy|August 24, 2000

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluidJ L Blackwell, H Li, J Gomez-Navarro, et al.

Human Gene Therapy|August 24, 2000

GST-pi gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity of cyclophosphamide in miceT Matsunaga, S Sakamaki, T Kuga, et al.

Pageof 413

Showing results (2041-2050 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|April 11, 2000

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell lineS Osanto, P P Schiphorst, N I Weijl, et al.

Human Gene Therapy|April 11, 2000

Retroviral preparations derived from PA317 packaging cells contain inhibitors that copurify with viral particles and are devoid of viral vector RNAJ Seppen, S Barry, G M Lam, et al.

Human Gene Therapy|April 25, 2000

Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA moleculeJ Lisziewicz, G Zeng, C Gratas, et al.

Human Gene Therapy|April 25, 2000

Photochemical transfection: a new technology for light-induced, site-directed gene deliveryA Høgset, L Prasmickaite, T E Tjelle, et al.

Human Gene Therapy|April 25, 2000

Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expressionJ M Vicat, S Boisseau, P Jourdes, et al.

Human Gene Therapy|August 17, 2000

Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's diseaseM Bauer, M Meyer, L Grimm, et al.

Human Gene Therapy|August 17, 2000

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapyY Chen, D C Yu, D Charlton, et al.

Human Gene Therapy|August 17, 2000

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutantJ Qiao, M E Black, M Caruso

Human Gene Therapy|August 24, 2000

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluidJ L Blackwell, H Li, J Gomez-Navarro, et al.

Human Gene Therapy|August 24, 2000

GST-pi gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity of cyclophosphamide in miceT Matsunaga, S Sakamaki, T Kuga, et al.

Pageof 413